SCHEMBL23657702

SCHEMBL23657702

CCN(CC)c1ncnc2sc(-c3ccccc3)cc12

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 6/20 0.72
MEN1 O00255 4/20 0.69
KMT2A Q03164 4/20 0.69
ATM Q13315 1/20 0.69
ALDH1A1 P00352 11/20 0.57
KDM4E B2RXH2 8/20 0.57
RAB9A P51151 5/20 0.57
NPC1 O15118 4/20 0.57
HPGD P15428 4/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
TSHR P16473 1/20 0.57
LMNA P02545 3/20 0.55
MAPT P10636 2/20 0.55
HTT P42858 1/20 0.55
RAD52 P43351 1/20 0.54
NFKB1 P19838 2/20 0.52
NFKB2 Q00653 2/20 0.52
RELA Q04206 2/20 0.52
CASP3 P42574 1/20 0.52
SENP8 Q96LD8 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14115105 0.78 ALDH1A1 (0.61) POLBMEN1KMT2AATMALDH1A1
SCHEMBL13708950 0.76 ALDH1A1 (0.66) POLBMEN1KMT2AALDH1A1KDM4E
SCHEMBL4416533 0.76 ALDH1A1 (0.61) POLBMEN1KMT2AATMALDH1A1
SCHEMBL2977154 0.73 ALDH1A1 (0.61) POLBMEN1KMT2AALDH1A1KDM4E
SCHEMBL14090773 0.72 ALDH1A1 (0.61) POLBMEN1KMT2AALDH1A1KDM4E
SCHEMBL15503823 0.70 RAD52 (1.00) POLBMEN1KMT2AALDH1A1KDM4E
SCHEMBL13331143 0.69 EGFR (0.79) MEN1KMT2AALDH1A1KDM4E
SCHEMBL16375362 0.69 EGFR (0.82) POLBMEN1KMT2AALDH1A1KDM4E
SCHEMBL11415260 0.68 LMNA (0.55) POLBKMT2AALDH1A1RAB9AHPGD
SCHEMBL29368679 0.68 KDM4E (0.82) POLBMEN1KMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210220408-A1 ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND METHODS OF USE EDIGENE BIOTECHNOLOGY, INC. (CN) 2021-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210220408-A1 ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND METHODS OF USE AHR, ARNT, ARSA POLB 3043/4885MEN1 4634/4885KMT2A 503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.